Cystic fibrosis (CF) is a genetic disorder produced by the loss of function of CFTR, a main chloride channel involved in transepithelial salt and water transport. CFTR function can be rescued by small molecules called “potentiators” which increase gating activity of CFTR on epithelial surfaces. High throughput screening (HTS) assays allowed the identification of new chemical entities endowed with potentiator properties, further improved through medicinal chemistry optimization. In this review, the most relevant classes of CFTR potentiators developed in the last decade were explored, focusing on structure-activity relationships (SAR) of the different chemical entities, as a useful tool for the improvement of their pharmacological activity.

Spano' V., Venturini A., Genovese M., Barreca M., Raimondi M.V., Montalbano A., et al. (2020). Current development of CFTR potentiators in the last decade. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 204 [10.1016/j.ejmech.2020.112631].

Current development of CFTR potentiators in the last decade

Spano' V.;Barreca M.;Raimondi M. V.;Montalbano A.
;
Barraja P.
2020-01-01

Abstract

Cystic fibrosis (CF) is a genetic disorder produced by the loss of function of CFTR, a main chloride channel involved in transepithelial salt and water transport. CFTR function can be rescued by small molecules called “potentiators” which increase gating activity of CFTR on epithelial surfaces. High throughput screening (HTS) assays allowed the identification of new chemical entities endowed with potentiator properties, further improved through medicinal chemistry optimization. In this review, the most relevant classes of CFTR potentiators developed in the last decade were explored, focusing on structure-activity relationships (SAR) of the different chemical entities, as a useful tool for the improvement of their pharmacological activity.
Spano' V., Venturini A., Genovese M., Barreca M., Raimondi M.V., Montalbano A., et al. (2020). Current development of CFTR potentiators in the last decade. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 204 [10.1016/j.ejmech.2020.112631].
File in questo prodotto:
File Dimensione Formato  
European Journal of Medicinal Chemistry 204 (2020) 112631.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 2.5 MB
Formato Adobe PDF
2.5 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/432865
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 15
  • ???jsp.display-item.citation.isi??? ND
social impact